Evidence map›Paper›PMID 40674422›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Accelerating countermeasure candidate discovery for A-series chemical warfare agent exposure.

Nicolás M Morato, Katelyn E Mason, Todd H Corzett, Carlos A Valdez, Teneile M Alfaro, Saphon Hok, R Graham Cooks, Brian P Mayer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Accelerated Chemistry in Microdroplets.Accounts of chemical research · 2026
    Article
  2. Article
  3. Chemical neighborhood exploration for substrate discovery in biocatalysis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Acetylcholinesterase: Structure, dynamics, and interactions with organophosphorus compounds.Protein science : a publication of the Protein Society · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicolás M MoratoPurdue Institute for Cancer Research, Purdue University, West Lafayette, IN 47907.
Katelyn E MasonForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0003-1809-9312
Todd H CorzettForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0002-9871-0988
Carlos A ValdezForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0002-8641-9077
Teneile M AlfaroForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0002-1970-0408
Saphon HokForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0002-8545-3628
R Graham CooksPurdue Institute for Cancer Research, Purdue University, West Lafayette, IN 47907.ORCID 0000-0002-9581-9603
Brian P MayerForensic Science Center, Global Security Principal Directorate, Lawrence Livermore National Laboratory, Livermore, CA 94550.ORCID 0000-0003-1967-9802

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDREW D MESECAR · 1985 to 2026
$43.4M
High throughput infrastructure for reaction screening and bioassaysUH3TR004139 · NCATS · PURDUE UNIVERSITY · PI Robert Graham Cooks · 2024 to 2026
$4.1M
High throughput infrastructure for reaction screening and bioassaysUG3TR004139 · NCATS · PURDUE UNIVERSITY · PI COOKS, ROBERT GRAHAM · 2022 to 2023
$1.8M
DOE | NNSA | Lawrence Livermore National Laboratory (LLNL) DE-AC52-07NA27344. LLNL-JRNL-2002371HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI) NIH P30 CA023168NCATS NIH HHS UG3 TR004139NCATS NIH HHS UH3 TR004139NCI NIH HHS P30 CA023168U.S. Department of Energy (DOE) DE-AC52-07NA27344. LLNL-JRNL-2002371
6 · The paper itself

Abstract

The recent alleged use of A-series chemical warfare agents (CWAs) highlights the urgent need to better understand their inhibition of cholinesterase enzymes and the reported shortcomings of traditional oxime countermeasures. Here, using high-throughput (HT) mass spectrometry (MS) technologies, we characterized the largely unknown inhibition kinetics of A-series CWAs on human acetylcholinesterase (

Indexed as

Chemical Warfare AgentsCholinesterase InhibitorsAcetylcholinesteraseCholinesterase ReactivatorsDrug DiscoveryHumansKineticsMass SpectrometryOrganothiophosphorus CompoundsOximesSarinAcetylcholinesteraseChemical Warfare AgentsCholinesterase InhibitorsCholinesterase ReactivatorsOrganothiophosphorus CompoundsOximesSarinVX-agentacetylcholinesteraseenzyme inhibitionhigh throughput reaction screeningmass spectrometrymedical countermeasures

Identifiers

PMID40674422
PMCPMC12304963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.